Patents by Inventor Linda Kadi

Linda Kadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAMENT AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS INVOLVING BIOFILM
    Publication number: 20230126947
    Abstract: The present invention relates to the use of Afabicin in a method of treating bacterial infections involving biofilm that contains Staphylococcus bacteria, wherein the method comprises administering Afabicin in combination with at least one further agent selected from lipopeptides, glycopeptides and lincosamides, such as Daptomycin and/or Vancomycin to the patient.
    Type: Application
    Filed: June 12, 2020
    Publication date: April 27, 2023
    Applicant: Debiopharm International S.A.
    Inventors: Justyna Nowakowska, Linda Kadi, Grégoire Vuagniaux
  • Medicament for treatment of diabetic foot infections
    Patent number: 10751351
    Abstract: The present invention provides means and methods for treating diabetic foot infections. In particular, drug compounds are provided that combine a high therapeutic activity against Staphylococcus Spp. bacteria with a high degree of bone penetration and vasodilatory effects. This unique combination of properties allows to accomplish high local concentrations of the drug at the site of infection even in diabetic foot patients typically having poor blood perfusion at the site of infection.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: August 25, 2020
    Assignee: Debiopharm International S.A.
    Inventors: Grégoire Vuagniaux, Linda Kadi, Frederick Wittke
  • MEDICAMENT FOR TREATMENT OF DIABETIC FOOT INFECTIONS
    Publication number: 20190054100
    Abstract: The present invention provides means and methods for treating diabetic foot infections. In particular, drug compounds are provided that combine a high therapeutic activity against Staphylococcus Spp. bacteria with a high degree of bone penetration and vasodilatory effects. This unique combination of properties allows to accomplish high local concentrations of the drug at the site of infection even in diabetic foot patients typically having poor blood perfusion at the site of infection.
    Type: Application
    Filed: February 27, 2017
    Publication date: February 21, 2019
    Inventors: Grégoire Vuagniaux, Linda Kadi, Frederick Wittke
  • Use of Sdf-1 for the Treatment and/or Prevention of Neurological Diseases
    Publication number: 20080253996
    Abstract: The invention relates to the use of SDF-1, or of an agonist of SDF-1 activity, for the treatment and/or prevention of a neurological disease.
    Type: Application
    Filed: October 30, 2006
    Publication date: October 16, 2008
    Applicant: LABORATORIES SERONO SA
    Inventors: Ursula Boschert, Amanda Proudfoot, Linda Kadi, Pierre Alain Vitte, Jerome Wojcik